{"SPADE_UN_15536": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15536", "Peptide Name": "[Trp]11 -Dec-NH2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "SLLSLIRKLIW", "Sequence Length": 11, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MCF-7 (IC50=25.0 µmol/L)", "Hemolytic Activity": "Human red blood cells:MHC=1.56 μmol/L", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C65H112N16O14", "Mass": 1341.68, "PI": 11.0, "Net Charge": 2, "Hydrophobicity": 1.21, "Half Life": "Mammalian:1.9 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Natural and redesigned wasp venom peptides with selective antitumoral activity", "Pubmed ID": "30013694", "Reference": "Beilstein J Org Chem. 2018 Jul 6;141693-1703.", "Author": "Torres MDT, Andrade GP, Sato RH, Pedron CN, Manieri TM, Cerchiaro G, Ribeiro AO, de la Fuente-Nunez C, Oliveira VX Jr.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30013694"}], "Frequent Amino Acids": "LIS", "Absent Amino Acids": "ACDEFGHMNOPQTUVY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 7, "Polar Residues": 4, "Positive Residues": 2, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_15062", "Similarity": 1.0, "Sequence": "LAGQGSPDLLGGHSLL"}, {"SPADE_ID": "SPADE_N_15476", "Similarity": 1.0, "Sequence": "YVPGVIESLL"}, {"SPADE_ID": "SPADE_N_15726", "Similarity": 1.0, "Sequence": "LDPKVVQSLL"}]}}}